Inventor · disambiguated record
Victor J. Torres
Also filed as: TORRES VICTOR J
20 granted patents·6 pending applications·49 citations·filing 2011–2023
93Inventor score
Top patents by PatentIndex Score
26 records- 0191US9644023B2Compositions and methods for phagocyte delivery of anti-staphylococcal agentsUNIV NEW YORK·Filed 2014·Granted May 9, 2017·19 cites·24 claims
- 0287US10781246B2Compositions and methods for anti-staphylococcal biologic agentsUNIV NEW YORK·Filed 2016·Granted Sep 22, 2020·5 cites·15 claims
- 0385US10202440B2Methods of treating and preventing Staphylococcus aureus infections and associated conditionsUNIV NEW YORK·Filed 2017·Granted Feb 12, 2019·3 cites·10 claims
- 0484US11584782B2Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereofUNIV NEW YORK·Filed 2019·Granted Feb 21, 2023·1 cites·11 claims
- 0583US8431687B2Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereofTORRES VICTOR J·Filed 2011·Granted Apr 30, 2013·6 cites·10 claims
- 0682US11453715B2Cellular factors involved in the cytotoxicity of Staphylococcus aureus leukocidins: novel therapeutic targetsUNIV NEW YORK·Filed 2020·Granted Sep 27, 2022·1 cites·7 claims
- 0782US9091689B2Methods of treating and preventing staphylococcus aureus infections and associated conditionsTORRES VICTOR J·Filed 2012·Granted Jul 28, 2015·4 cites·9 claims
- 0879US2023295248A1Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereofUNIV NEW YORK·Filed 2023·Application pending·0 cites
- 0978US11932683B2Cellular factors involved in the cytotoxicity of Staphylococcus aureus leukocidins: novel therapeutic targetsUNIV NEW YORK·Filed 2022·Granted Mar 19, 2024·0 cites·23 claims
- 1078US10301378B2Cellular factors involved in the cytotoxicity of Staphylococcus aureus leukocidins: novel therapeutic targetsUNIV NEW YORK·Filed 2014·Granted May 28, 2019·3 cites·12 claims
- 1177US8846609B2Leukotoxin E/D as a new anti-inflammatory agent and microbicideTORRES VICTOR J·Filed 2012·Granted Sep 30, 2014·3 cites·5 claims
- 1276US10669329B2Methods of treating and preventing Staphylococcus aureus infections and associated conditionsUNIV NEW YORK·Filed 2019·Granted Jun 2, 2020·0 cites·15 claims
- 1376US2021340228A1Methods of treating and preventing staphylococcus aureus infections and associated conditionsUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 1475US10316067B2Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereofUNIV NEW YORK·Filed 2017·Granted Jun 11, 2019·1 cites·6 claims
- 1574US11078258B2Methods of treating and preventing Staphylococcus aureus infections and associated conditionsUNIV NEW YORK·Filed 2020·Granted Aug 3, 2021·0 cites·8 claims
- 1671US11104724B2Compositions and methods for antibodies targeting staphylococcal leukotoxinsUNIV NEW YORK·Filed 2017·Granted Aug 31, 2021·1 cites·4 claims
- 1771US9480726B2Leukotoxin E/D as a new anti-inflammatory agent and microbicideUNIV NEW YORK·Filed 2014·Granted Nov 1, 2016·1 cites·8 claims
- 1870US9783582B2Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereofTORRES VICTOR J·Filed 2011·Granted Oct 10, 2017·1 cites·3 claims
- 1963US9783597B2Methods of treating and preventing Staphylococcus aureus infections and associated conditionsTORRES VICTOR J·Filed 2016·Granted Oct 10, 2017·0 cites·14 claims
- 2059US2019248876A1Cellular factors involved in the cytotoxicity of staphylococcus aureus leukocidins: novel therapeutic targetsUNIV NEW YORK·Filed 2019·Application pending·0 cites
- 2158US9481723B2Methods of treating and preventing Staphylococcus aureus infections and associated conditionsTORRES VICTOR J·Filed 2015·Granted Nov 1, 2016·0 cites·8 claims
- 2258US2025281591A1Staphylococcus aureus vaccine compositionsJANSSEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2356US10087243B2Compositions and methods for phagocyte delivery of anti-staphylococcal agentsUNIV NEW YORK·Filed 2017·Granted Oct 2, 2018·0 cites·23 claims
- 2455US2024050546A1Variant staphylococcus aureus luka and lukb polypeptides and vaccine compositionsJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2549US2017224768A1Leukotoxin e/d as a new anti-inflammatory agent and microbicideUNIV NEW YORK·Filed 2016·Application pending·0 cites
- 2643US9657103B2Methods of treating and preventing Staphylococcus aureus infections and associated conditionsUNIV NEW YORK·Filed 2013·Granted May 23, 2017·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →